EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Tacrolimus Toxicity Induced by Nirmatrelvir/Ritonavir in a Renal Transplant Recipient Managed With Phenytoin: A Case Report and Literature Review

Ching-Yu Wang, Cheng-Hsu Chen, Shang-Feng Tsai

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2025.06.019 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Ching-Yu Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Kidney Transplantation, Ritonavir, Phenytoin, Tacrolimus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: Taichung Veterans General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The COVID-19 pandemic has led to widespread use of nirmatrelvir/ritonavir in high-risk populations. Ritonavir, a strong CYP3A4 inhibitor, can significantly increase tacrolimus levels, causing toxicity in transplant recipients. This report presents a case of nirmatrelvir/ritonavir -induced tacrolimus toxicity in a kidney transplant patient, successfully managed with phenytoin, a CYP3A4 inducer. CASE REPORT: A 63-year-old male kidney transplant recipient experienced malaise and hand tremors after nirmatrelvir/ritonavir treatment for mild COVID-19. Lab tests revealed ac1ute kidney injury and supratherapeutic tacrolimus levels (>60 ng/mL). Tacrolimus was discontinued, and hydration was initiated. Persistent toxicity required phenytoin, leading to rapid improvement. A renal biopsy showed no toxicity, and the patient was discharged without complications. DISCUSSION: Among 51 reported cases of nirmatrelvir/ritonavir -induced tacrolimus toxicity, 13 used CYP3A4 inducers. This case highlights phenytoin's efficacy in reducing toxicity and protecting renal function. Timely initiation with a loading dose is crucial for optimal outcomes. CONCLUSION: Early recognition and prompt management with hydration and CYP3A4 inducers, such as phenytoin, are essential in mitigating nirmatrelvir/ritonavir -associated tacrolimus toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationRitonavirPhenytoinTacrolimusImmunosuppressive AgentsHumansMaleMiddle AgedCOVID-19COVID-19 Drug Treatment

Substanzen

RitonavirPhenytoinTacrolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Department of Life Science, Tunghai University, Taichung, Taiwan; Department of Post-Baccalaureate Medicine,…

Förderung

  • Taichung Veterans General Hospital

Zitieren

APA

Wang, C. Y., Chen, C. H., & Tsai, S. F. (2025). Tacrolimus Toxicity Induced by Nirmatrelvir/Ritonavir in a Renal Transplant Recipient Managed With Phenytoin: A Case Report and Literature Review. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.06.019

Vancouver

Wang CY, Chen CH, Tsai SF. Tacrolimus Toxicity Induced by Nirmatrelvir/Ritonavir in a Renal Transplant Recipient Managed With Phenytoin: A Case Report and Literature Review. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.06.019

BibTeX
@article{Wang2025,
  author = {Wang, Ching-Yu and Chen, Cheng-Hsu and Tsai, Shang-Feng},
  title = {Tacrolimus Toxicity Induced by Nirmatrelvir/Ritonavir in a Renal Transplant Recipient Managed With Phenytoin: A Case Report and Literature Review},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2025.06.019}
}
Kostenlos starten →